Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.
about
A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype JReview of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyRecent advances in understanding and diagnosing hepatitis B virus infectionSerum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis BQuantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients.Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assayHBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b.Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.New perspectives of biomarkers for the management of chronic hepatitis B.Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy.Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B.Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analogue treatment.Prospects and progress of DNA vaccines for treating hepatitis B.Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy.Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.Serum HBV core-related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients.Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy.Flow injection/sequential injection analysis systems: potential use as tools for rapid liver diseases biomarker study.Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.JSH Guidelines for the Management of Hepatitis B Virus Infection.Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.Anti-hepatitis B virus therapy: To stop, or not to stop: Has the question been solved?Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels.Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B.Looking into the crystal ball: biomarkers for outcomes of HBV infection.Global strategies are required to cure and eliminate HBV infection.Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.Viral Biomarkers in Chronic HBeAg Negative HBV Infection
P2860
Q24646080-0223B982-0FF6-4197-A1A9-9DE82678D927Q26740161-C648AB66-BB4D-4FD4-A528-D103E60B5BE4Q28067419-A3CF72AA-ABB4-451C-B0DF-BED31BBADDCDQ33669333-7EB60E08-4930-45AB-AB3E-0B4C5F0EBB94Q36351904-AB0759B7-7B2F-46E8-806B-51A67BA5A754Q37135543-630E9B4E-9B0B-4C1A-A59B-F9954654F2A0Q37255017-2923F0EC-694C-4A15-81DD-FFF36FE266A8Q37470263-6F867CB6-8C64-4162-A164-1EA00BA8BA1BQ37606546-075F08B4-8F3A-4041-BE28-BB0E0EB8E7F6Q37727852-A0A23904-61CC-421B-A14C-6E3A403C044BQ37798175-3A36A114-0B9D-4F71-9A9B-A21C6657622FQ38100847-387017D3-E5CF-4DF8-B188-3D11A85691D7Q38596871-B9F3CD29-0FD8-43F6-B684-1B7E1BEB87C9Q38664504-1BC9E5D9-27B7-43EA-913A-44D359F3005CQ40078747-AB4C9446-865C-494E-8880-006BBF08843DQ40341578-3D8AA688-318C-47F6-A391-4283EE60E1FEQ40404314-B0C998E9-9086-4756-A1AB-5CAC6DA1E24FQ40575142-0CFCA9B5-61B8-4371-A0BB-745E262313B0Q40582667-858338F2-8860-476A-821B-FC2753DC7F1EQ40706734-6A613231-F620-4637-8557-E08F91C2D8E8Q41042019-957EBFC4-6A6C-4CC2-AB89-85BF48284F62Q41673544-015A8706-6BA0-4580-8C8C-4346CD751DCBQ41978670-BD0B8283-0DD3-40EE-83A0-55DA5CFFC510Q42174830-DE8339EB-3FBB-4956-93B1-26B3676A254EQ42244740-D48AE8F5-9D3B-478F-9B87-720645A71496Q42262670-D1BBFE47-484C-4822-AC40-64A2095D8CFEQ44646819-5DA52557-181A-4BB0-A536-4BEC5EB9FD64Q45326295-2F0D3B6F-BD3F-4BC4-8325-17C7C39E61CDQ45355602-42C96FEF-7CB1-4A63-9828-936536B20BC0Q46720186-EF9F9505-9317-4FF7-9D98-DE6417483D3FQ47575314-ADEA6832-C78F-41D8-B777-78ECB5763872Q48263897-C98D5851-C826-42E7-A6CF-8DDD294517D9Q48860247-B96B496E-51B5-4436-B931-A4398D1B7AE1Q50522258-28B6B65F-F546-4743-BD31-F99D3B050F96Q55276444-2F968EE6-FCFE-418D-B130-5FA33BBE2C93Q59126856-1D9B3A20-3F6B-4923-A702-72E9DE22B03D
P2860
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@ast
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@en
type
label
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@ast
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@en
prefLabel
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@ast
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@en
P2093
P2860
P356
P1476
Hepatitis B virus core-related ...... chronic hepatitis B infection.
@en
P2093
Danny Ka-Ho Wong
Man-Fung Yuen
Masashi Mizokami
Yasuhito Tanaka
P2860
P304
P356
10.1128/JCM.00366-07
P407
P577
2007-10-17T00:00:00Z